Lexology June 15, 2022
Robinson & Cole LLP

On June 15, 2022, the U.S. Supreme Court unanimously ruled in favor of “340B” hospitals in a notable statutory interpretation case concerning how the federal Medicare program reimburses hospitals for prescription drugs. The case, which was brought by the American Hospital Association, arises from reimbursement reductions imposed by the Department of Health and Human Services (HHS) in 2018 and 2019 on hospitals participating in the 340B program (which the Court noted are hospitals that “generally serve low-income or rural communities”). In those years, HHS sought to impose reductions in reimbursement due to favorable pricing available to 340B hospitals under that program. The hospitals challenged those reductions based on the process HHS followed when setting the reimbursement rates, claiming that HHS’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Health System / Hospital, HHS, Insurance, Medicare, Pharma, Pharma / Biotech, Provider
GE, LG, Microsoft tie up for smart hospital project in Korea
How technology is bringing cardiology, cardiac surgery together
The Digital Transformation of Nursing
Feds Seeking to Save Medicare Money on High-Volume, High-Cost Procedures
Mayo Clinic $5B expansion sparks financial planning reboot

Share This Article